KalVista Pharmaceuticals (KALV) Files $300M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Form S-3 KalVista Pharmaceuticals
July 11, 2024 4:50 PM EDTTable of Contents
As filed with the Securities and Exchange Commission on July 11, 2024
Registration No. 333-
... More
